Depression and anxiety in COPD

Depression and anxiety in COPD are standard in patients with chronic obstructive pulmonary disease (COPD), evaluations of their pervasiveness differ significantly. These likely reflect the variety of scales and techniques used to measure such symptoms. Patients with COPD with three or more comorbidities more likely to be frequently hospitalized and may die prematurely compared with COPD patients without comorbidities. An uplifted experience of dyspnoea is likely contributing segment to nervousness. Feelings of depression may be precipitated by the loss and grief related with the inability of COPD. Smoking has been related with nicotine addiction, and the variables that contribute to smoking may also predispose to anxiety and depressive disorders. The cause of depression and anxiety manifestations are multifactorial and include behavioural, social and biological factors. COPD Conferences paves a way towards a break-through in pulmonology research field.


  • Prevalence in COPD
  • Classification and diagnostic criteria
  • Clinical features and impact
  • Screening and diagnosis
  • Risk factors
  • Mechanism of potential association with COPD

Related Conference of Depression and anxiety in COPD

March 18-19, 2020

11th Annual Congress on Pulmonology & Respiratory Medicine

Amsterdam, Netherlands
June 29-30, 2020

International Conference on Probiotics and Prebiotics

Frankfurt, Germany
October 12-13, 2020

World Congress and Expo Pulmonology

Manila, Philippines
October 12-13, 2020

International Congress and Expo on Pulmonology

Manila, Philippines
October 29-30, 2020

International Conference on Lung Diseases

Cape Town, South Africa
November 18-19, 2020

International Conference on Asthma and Allergy

Lisbon, Portugal
December 7-8, 2020

8th Annual Congress on Pulmonary and Critical Care

Tokyo, Japan

Depression and anxiety in COPD Conference Speakers

Recommended Sessions

Related Journals

Are you interested in